2016 ASCO Annual Meeting Abstract 8001: Lenalidomide (LEN) Maintenance (MNTC) After High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Multiple Myeloma (MM): A Meta-Analysis (MA) of Overall Survival (OS)

This large MA demonstrates that LEN MNTC significantly prolonged OS vs CTL post ASCT, including in pts who achieved CR, demonstrating benefit in pts in all response categories.